• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Managed Care Cast Presents: Navigating Burdens and Treatment Challenges of IPF

Commentary
Podcast

A trio of experts discuss the importance of early diagnosis, treatment barriers, and therapies in the pipeline for idiopathic pulmonary fibrosis (IPF).

Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF).

In this podcast, you’ll hear insight from the following individuals:

  • Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, University of Southern California
  • Martin Kolb, MD, PhD, professor of medicine, McMaster University
  • Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia

These experts discuss what IPF is, how it impacts patients’ quality of life, barriers to care, and treatments in the pipeline.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.